Showing results (1191-1200 of 16,174) with videos related to

Sort By:
Pageof 1,618
European Journal of Medicinal Chemistry|May 17, 2022
Study of the anticancer potential of Cd complexes of selenazoyl-hydrazones and their sulfur isostersSanja B Marković, Natalia Maciejewska, Mateusz Olszewski, et al.
European Journal of Medicinal Chemistry|May 20, 2022
Identification and development of a series of disubstituted piperazines for the treatment of Chagas diseaseKate McGonagle, Gary J Tarver, Juan Cantizani, et al.
European Journal of Medicinal Chemistry|July 25, 2021
Design and synthesis of novel orally selective and type II pan-TRK inhibitors to overcome mutations by property-driven optimizationMu-Chun Li, Wen-Hsing Lin, Pei-Chen Wang, et al.
European Journal of Medicinal Chemistry|July 15, 2021
Optimization of peptide-based inhibitors targeting the HtrA serine protease in Chlamydia: Design, synthesis and biological evaluation of pyridone-based and N-Capping group-modified analoguesJimin Hwang, Natalie Strange, Matthew J A Phillips, et al.
European Journal of Medicinal Chemistry|December 22, 2017
Design and characterization of α-lipoic acyl shikonin ester twin drugs as tubulin and PDK1 dual inhibitorsHong-Yan Lin, Hong-Wei Han, Wen-Xue Sun, et al.
European Journal of Medicinal Chemistry|December 24, 2017
Branching tryptamines as a tool to tune their antiproliferative activityRinat F Salikov, Konstantin P Trainov, Irina K Belousova, et al.
European Journal of Medicinal Chemistry|December 24, 2017
Colchicine prodrugs and codrugs: Chemistry and bioactivitiesAbdullah A Ghawanmeh, Kwok Feng Chong, Shaheen M Sarkar, et al.
European Journal of Medicinal Chemistry|December 25, 2017
Discovery of anilino-furo[2,3-d]pyrimidine derivatives as dual inhibitors of EGFR/HER2 tyrosine kinase and their anticancer activityMonia Hossam, Deena S Lasheen, Nasser S M Ismail, et al.
European Journal of Medicinal Chemistry|December 31, 2017
Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cellsYong Ling, Jing Guo, Qiuxing Yang, et al.
European Journal of Medicinal Chemistry|December 31, 2017
Biological evaluation of indolizine-chalcone hybrids as new anticancer agentsSujin Park, Eun Hye Kim, Jinwoo Kim, et al.
Pageof 1,618